Baird Downgrades Itron to Neutral, Lowers Price Target to $75
Baird analyst Ben Kallo downgrades Itron (NASDAQ:ITRI) from Outperform to Neutral and lowers the price target from $100 to $75.
Raymond James Upgrades Itron to Strong Buy, Announces $98 Price Target
Raymond James analyst Pavel Molchanov upgrades Itron (NASDAQ:ITRI) from Outperform to Strong Buy and announces $98 price target.
Mid-Day Market Update: Dow Surges 200 Points; Itron Shares Tumble Following Q2 Downbeat Earnings
Midway through trading Thursday, the Dow traded up 0.58% to 34,992.85 while the NASDAQ rose 0.61% to 14,870.44. The S&P also rose, gaining 0.14% to 4,420.81.
Mid-Morning Market Update: Markets Open Higher; Kellogg Tops Q2 Views
Following the market opening Thursday, the Dow traded up 0.49% to 34,961.76 while the NASDAQ rose 0.39% to 14,837.81. The S&P also rose, gaining 0.34% to 4,417.73.
Itron Q2 EPS $0.28 Misses $0.48 Estimate, Sales $489.00M Miss $535.91M Estimate; Cuts Guidance
Itron (NASDAQ:ITRI) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.48 by 41.67 percent. This is a 833.33 percent increase over earnings of $0.03 per share from the same
Earnings Scheduled For August 5, 2021
Companies Reporting Before The Bell
• OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.